BeStock  

InnovAge Holding INNV

US equityMarket cap rank #3015Medical Care Facilities
$9.16 +$0.25 (+2.81%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $9.16 0.00%
Open$8.84
Prev close$8.91
Day range$8.84 – $9.22
Volume498.4K
Market cap$1.25B
P/E (TTM)152.7
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

INNV at a glance

InnovAge Holding stock (INNV) sits at $9.16, up 2.81% today. The business is worth $1.25B in the market, good for #3015 of 3753 on our coverage list.

Over a full year the shares have ranged across $4.70 to $12.64, which puts the current price roughly 56% of the way up that band. Holders are ahead 74.5% over twelve months, but down 16.9% across the last three months.

On the chart it has slipped under both the 50-day ($9.36) and 200-day ($9.31) moving averages; RSI is 48, and the last 30 sessions moved at roughly 48% annualized volatility.

In the quarter ended Sep 2026 the company brought in $264.76M of revenue, up 12.1% from a year earlier, with $20.88M of net profit (a 0.9% margin).

Buyers are paying 152.7 times trailing earnings, 10,766% above its five-year average of 1.4. The median for its industry group is 20.4.

3 analysts follow the stock and the average call is "hold". The mean target, $12.00, sits 31.0% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$7.00 / $9.40
Average price today$9.10
Volume498.4KAvg (90d) 491.3K
Turnover$4.54M
Turnover rate1.45%of shares outstanding
Volume ratio1.10vs. recent average pace
Day amplitude4.27%
Market cap$1.25B
Float market cap$315.14M
Shares outstanding34.40M
EPS (TTM)-$0.02
P/E (TTM)152.67
P/B4.90
Book value / share$1.87
Earnings yield0.66%
Net profit (TTM)-$2.73M
Net assets$255.31M
30-day volatility48.5%annualized
Avg daily range (ATR)6.05%of price, 14 days
Max drawdown (1y)-33.2%-24.4% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

D
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

F
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

D
Momentum

Trading closer to its 52-week high than most peers scores higher.

C
Wall Street

3 analysts, consensus Hold.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 8.7 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation19.2
Growth—
Profitability18.4
Momentum70.0
Financial health30.6
Analyst view30.3

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$12.00+31.0% vs. current price
Consensus ratingHold3 analysts covering
Morningstar fair value$8.19Price is above fair value

Wall Street’s average 12-month target is $12.00, 31.0% above today’s price, with a consensus rating of Hold. Morningstar’s fair value model puts the stock at $8.19, so shares trade 11.8% above that estimate. On earnings multiple, it sits in the 91st percentile of its own five-year valuation range (pricier than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
+2.8%
1 week
-3.3%
1 month
-3.8%
3 months
-16.9%
6 months
+27.2%
Year to date
+76.5%
1 year
+74.5%
Day range
$8.84$9.22
52-week range
$4.70$12.64

Technical signals

Full technicals →
Trend readStrong downtrend

1 bullish · 6 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-0.7%Bearish
Price vs 50-day average-2.1%Bearish
Price vs 200-day average-1.6%Bearish
50-day vs 200-day50d above 200dBullish
RSI (14)47.9Bearish
MACD (12,26,9)-0.05Bearish
Bollinger band position44%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How INNV ranks on BeStock

Market value#3003 of 3734
P/E (cheapest = 1)#2856 of 2917
Closeness to 52-week high#1993 of 3724
Dollar volume today#2725 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

Set against the peer table: at 152.7x earnings, INNV looks expensive against the market, and trades 649% above the 20.4x median among Medical Care Facilities names. The two comparisons do not always agree.

INNV is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on INNV.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on INNV

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

INNV stock: common questions

Where is INNV trading right now?

$9.16 is the latest print for INNV, a move of +2.81% against yesterday's close of $8.91. Today's low and high so far: $8.84 and $9.22.

How big is InnovAge Holding?

Equity value comes to $1.25B at the current price. By that measure it is number 3015 of the 3753 names in our coverage.

What multiple of earnings does INNV sell for?

Buyers pay 152.7 times the last twelve months of profit (EPS $-0.02). Averaged over five years the multiple has been 1.4, and today's level ranks in the 91st percentile of its own history.

What's the 52-week trading range for InnovAge Holding?

The year's floor is $4.70 and the ceiling $12.64. Shares are 27.5% away from that ceiling.

What's the dividend situation for INNV?

Our data shows no dividend paid by InnovAge Holding over the trailing twelve months.

What are analysts saying about INNV?

Of 3 analysts, 33% say buy, 33% hold and 33% sell. Price targets average $12.00, with the most cautious at $10.00 and the most optimistic at $14.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on INNV.

Sign in to join the discussion.

Scroll to Top